Health

News and Articles on Ayurveda, Yoga, Kundalini and other Indian way of health and medicines.

ICMR has Approved Nine Systems for Molecular Testing of SARS-CoV-2

In continuation to the “Algorithm: Guidelines for International Arrivals dated 28th November 2021” issued by Ministry of Health and Family Welfare(MoHFW), the following Frequently Asked Questions(FAQs) are being issued for better understanding of the passengers and to enable them for safe, secure and hassle-free International Air Travel. It may be noted that these steps are being taken to ensure the good health and safety of every citizen of the country so that the subsequent problems do not arise.

Usage of Anti-Diabetics Ayurvedic Drug Bgr-34

The drug BGR-34 is available to the patients in the country since 2015.The formulation was developed and required scientific studies were carried out by National Botanical Research Institute (NBRI) and Central Institute of Medicinal and Aromatic Plants (CIMAP), research units functioning under Council of Scientific and Industrial Research (CSIR). The tests include standardization, product validation on the basis of modern scientific parameters, antioxidant activity determination, optimization of herbal components for best activity, assessment of anti-diabetic activity and safety studies etc.

Government of India Continues to Keep Track of the Evolving Situation; Home Secretary Chairs High Level Review Meeting

The Union Health Secretary has advised  States/UTs regarding testing, surveillance, monitoring of hotspots, augmentation of health infrastructure, genome sequencing, and enhancing public awareness, vide his letters dated 25th and 27th of November 2021, the first of which was immediately after WHO flagged the Omicron variant as a Variant of Concern (VoC).

SWADESH, World’s First Multimodal Brain Imaging Data and Analytics, Developed at DBT-National Brain Research Centre, Haryana

SWADESH is supported by JAVA-based workflow environment and Python. Backed by a dedicated storage system, it provides quality control, data analysis reports, and data backups. Its development will facilitate the integration of multi-site data and collaborative research worldwide. Presently, SWADESH has data of 500 AD and MCI patients and 70 PD patients. It also includes data of 600 healthy old individuals and 800 healthy young individuals in the control group.